XZXuejun Zhu

Xuejun Zhu

*This is an algorithmically generated author record based on publicly available information.

Xuejun Zhu has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structural basis for TrbM-enhanced conjugation and interbacterial killing in the RP4 plasmid

    by Lois Gordils-Valentin, Jackson Belobrajdic, Xuejun Zhu

  • Open Access

    Conjugative type IV secretion systems enable bacterial antagonism that operates independently of plasmid transfer

    by Lois Gordils-Valentin, Huanrong Ouyang, Liangyu Qian, Joshua Hong, Xuejun Zhu

    Bacterial cooperation and antagonism mediated by secretion systems are among the ways in which bacteria interact with one another. Here we report the discovery of an antagonistic property of a type IV secretion system (T4SS) sourced from a conjugative plasmid, RP4, using engineering approaches. We scrutinized the genetic determinants and suggested that this antagonistic activity is independent of molecular cargos, while we also elucidated the resistance genes. We further showed that a range of Gram-negative bacteria and a mixed bacterial population can be eliminated by this T4SS-dependent antagonism. Finally, we showed that such an antagonistic property is not limited to T4SS sourced from RP4, rather it can also be observed in a T4SS originated from another conjugative plasmid, namely R388. Our results are the first demonstration of conjugative T4SS-dependent antagonism between Gram-negative bacteria on the genetic level and provide the foundation for future mechanistic studies.


  • Open Access

    Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning

    by Huanrong Ouyang, Zhao Xu, Joshua Hong, Jeshua Malroy, Liangyu Qian, Shuiwang Ji, Xuejun Zhu

    Anaerobes dominate the microbiota of the gastrointestinal (GI) tract, where a significant portion of small molecules can be degraded or modified. However, the enormous metabolic capacity of gut anaerobes remains largely elusive in contrast to aerobic bacteria, mainly due to the requirement of sophisticated laboratory settings. In this study, we employed an in silico machine learning platform, MoleculeX, to predict the metabolic capacity of a gut anaerobe, Clostridium sporogenes, against small molecules. Experiments revealed that among the top seven candidates predicted as unstable, six indeed exhibited instability in C. sporogenes culture. We further identified several metabolites resulting from the supplementation of everolimus in the bacterial culture for the first time. By utilizing bioinformatics and in vitro biochemical assays, we successfully identified an enzyme encoded in the genome of C. sporogenes responsible for everolimus transformation. Our framework thus can potentially facilitate future understanding of small molecules metabolism in the gut, further improve patient care through personalized medicine, and guide the development of new small molecule drugs and therapeutic approaches.

  • Open Access

    Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning

    by Huanrong Ouyang, Zhao Xu, Joshua Hong, Jeshua Malroy, Liangyu Qian, Shuiwang Ji, Xuejun Zhu

    Anaerobes dominate the microbiota of the gastrointestinal (GI) tract, where a significant portion of small molecules can be degraded or modified. However, the enormous metabolic capacity of gut anaerobes remains largely elusive in contrast to aerobic bacteria, mainly due to the requirement of sophisticated laboratory settings. In this study, we employed an in silico machine learning platform, MoleculeX, to predict the metabolic capacity of a gut anaerobe, Clostridium sporogenes, against small molecules. Experiments revealed that among the top seven candidates predicted as unstable, six indeed exhibited instability in C. sporogenes culture. We further identified several metabolites resulting from the supplementation of everolimus in the bacterial culture for the first time. By utilizing bioinformatics and in vitro biochemical assays, we successfully identified an enzyme encoded in the genome of C. sporogenes responsible for everolimus transformation. Our framework thus can potentially facilitate future understanding of small molecules metabolism in the gut, further improve patient care through personalized medicine, and guide the development of new small molecule drugs and therapeutic approaches.


  • Open Access

    Specific residues and conformational plasticity define the substrate specificity of short-chain dehydrogenases/reductases

    by Liangyu Qian, Priyesh Mohanty, Arul Jayaraman, Jeetain Mittal, Xuejun Zhu


  • Top Cited Papers
    Open Access

    Polyethylene Degradation by a Rhodococcous Strain Isolated from Naturally Weathered Plastic Waste Enrichment

    by Xuanyu Tao, Huanrong Ouyang, Aifen Zhou, Dongyu Wang, Hagan Matlock, Josiah S. Morgan, Abigail T. Ren, Dashuai Mu, Chongle Pan, Xuejun Zhu, et al.

    Polyethylene (PE) is the most widely produced synthetic polymer and the most abundant plastic waste worldwide due to its recalcitrance to biodegradation and low recycle rate. Microbial degradation of PE has been reported, but the underlying mechanisms are poorly understood. Here, we isolated a Rhodococcus strain A34 from 609 day enriched cultures derived from naturally weathered plastic waste and identified the potential key PE degradation enzymes. After 30 days incubation with A34, 1% weight loss was achieved. Decreased PE molecular weight, appearance of C-O and C═O on PE, palmitic acid in the culture supernatant, and pits on the PE surface were observed. Proteomics analysis identified multiple key PE oxidation and depolymerization enzymes including one multicopper oxidase, one lipase, six esterase, and a few lipid transporters. Network analysis of proteomics data demonstrated the close relationships between PE degradation and metabolisms of phenylacetate, amino acids, secondary metabolites, and tricarboxylic acid cycles. The metabolic roadmap generated here provides critical insights for optimization of plastic degradation condition and assembly of artificial microbial communities for efficient plastic degradation.


  • Open Access

    Research on Autonomous Navigation of Two Wheel-leg Robot in Indoor Dynamic Environment

    by Xinzhi Ma, Huige Lai, Qiongyang Wen, Xuejun Zhu, Aidi Yang, Haifu Li

    The object of this paper is the autonomous navigation control system of the two wheel-leg robot in indoor dynamic environment. To give full play to the kinematic ability of the two wheel-leg robot, the terrain adaptation ability of the leg structure and the control ability of the upper layer autonomous navigation system, the multi-mode control method of the robot and the path planning and autonomous navigation in indoor environment are studied in this paper. Firstly, based on the simulation physics platform, the kinematic transfer relationship of distributed model was proposed, the kinematic model of the wheel-leg subsystem and the two wheel-leg system was established, and the full-drive dynamic model with the wheel-leg-torso interaction force as the end output force was established. Then, a distributed control framework with torso postures as task space was proposed to plan the torso force and joint torque of the body in layers. The proposed walking and jumping motion planner of the two wheel-leg system and the multi-mode state machine are integrated with the control frame to realize the wheeled walking and jumping smooth control of the sagittal plane wheel-leg coordination. Finally, the ROS software framework based RGB-D visual sensor SLAM local environment awareness system is used to convert the point cloud map into an octree map, and then the oblique projection principle is converted into a two-dimensional raster map. A * algorithm and TEB algorithm are respectively used for global and local path planning. Finally, the autonomous navigation ability of the two wheel-leg robot in indoor dynamic environment is realized.


  • Identification of Gut Bacterial Enzymes for Keto-Reductive Metabolism of Xenobiotics

    by Liangyu Qian, Huanrong Ouyang, Lois Gordils-Valentin, Joshua Hong, Arul Jayaraman, Xuejun Zhu

    Human gastrointestinal microbiota are known for the keto-reductive metabolism of small-molecule pharmaceuticals; however, the responsible enzymes remain poorly understood. Through in vitro biochemical assays, we report the identification of enzymes encoded in the genome of Clostridium bolteae that can reduce the ketone groups of nabumetone, hydrocortisone, and tacrolimus. The homologues to a newly identified enzyme (i.e., DesE) are potentially widely distributed in the gut microbiome. The selected enzymes display different levels of activities against additional chemicals such as two dietary compounds (i.e., raspberry ketone and zingerone), chemotherapeutic drug doxorubicin, and its aglycone metabolite doxorubicinone. Thus, our results expand the repertoire of enzymes that can reduce the ketone groups in small molecules and could serve as the basis for future personalized medicine approaches.


  • An E. coli-Based Biosynthetic Platform Expands the Structural Diversity of Natural Benzoxazoles

    by Huanrong Ouyang, Joshua Hong, Jeshua Malroy, Xuejun Zhu

    Benzoxazoles are frequently found in synthetic pharmaceuticals and medicinally active natural products. To facilitate benzoxazole-based drug development, an eco-friendly and rapid platform for benzoxazole production is required. In this study, we have completed the biosynthesis of benzoxazoles in E. coli by coexpressing the minimal set of enzymes required for their biosynthesis. Moreover, by coupling this E. coli-based platform with precursor-directed biosynthesis, we have shown that the benzoxazole biosynthetic system is highly promiscuous in incorporating fluorine, chlorine, nitrile, picolinic, and alkyne functionalities into the scaffold. Our E. coli-based system thus paves the way for straightforward generation of novel benzoxazole analogues through future protein engineering and combinatorial biosynthesis.